HARBIN, Jan. 23 (CNR News) — On the afternoon of January 22nd, Zhejiang OrientGene

Biopharmaceutical Co., Ltd., themed "Silver City of Ice and Snow, Jointly Creating Brilliance," held a signing ceremony and quantum dot new product launch event in Harbin.

Signing Ceremony (Photo provided by CNR Network, photographer Liu Xia)

OrientGene Company's newly developed and soon-to-be-produced in vitro diagnostic reagents (Photo provided by CNR Network, photographer Liu Xia)

In recent years, the Harbin Municipal Party Committee and Government have prioritized the development of the bio-economy, particularly leveraging the International Bio-Valley constructed in Pingfang District (Harbin Economic and Technological Development Zone), which has formed a unique industrial cluster advantage. Currently, there are 67 enterprises above designated size in the bio-economy sector in Pingfang District (Harbin ETZ), with an industry scale reaching 14.3 billion RMB in 2023.

It is reported that OrientGene, which settled in Pingfang District (Harbin ETZ) on January 1, 2023, is a listed export-oriented enterprise specializing in IVD reagents, possessing strong R&D and innovation capabilities, with products sold in over 120 countries and regions globally. The signing parties will leverage their respective strengths, broaden cooperation areas, and effectively contribute to the construction of "Six Longjiangs" and the creation of "Seven Major Cities."

For more exciting news, please download the "CNR Network" app from the app store. Tips for news stories are welcome through our 24-hour hotline at 400-800-0088. Consumers can also file complaints online through CNR Network’s “Woodpecker Consumer Complaint Platform.” Copyright Statement: This article is owned by CNR Network. Unauthorized reproduction is prohibited. For republication, please contact: cnrbanquan@cnr.cn. Acts of disrespect towards original content will be pursued for liability.